Dianthus Therapeutics, Inc. /De/
DNTH
Revenue
193.00k
▼-970.00k▼-83.40%
3 Months ChangeAssets
326.08M
▼-22.50M▼-6.46%
3 Months ChangeLiabilities
23.00M
▲3.02M▲15.13%
3 Months ChangeFree Cash Flow
-10.53M
▲9.24M▲46.74%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-09-16
Form 8-K
ID: 0000950170-24-106820
2024-08-08
Form 10-Q
ID: 0000950170-24-093948
2024-08-08
Form 8-K
ID: 0000950170-24-093920
2024-06-06
Form 8-K
ID: 0000950170-24-069675
2024-05-28
Form 8-K
ID: 0000950170-24-065371
2024-05-09
Form 10-Q
ID: 0000950170-24-057022
2024-05-09
Form 8-K
ID: 0000950170-24-056925
2024-03-21
Form 8-K
ID: 0000950170-24-034667
2024-01-22
Form 8-K
ID: 0001193125-24-011681
2024-01-08
Form 8-K
ID: 0000950170-24-002707